1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphereUnresectable Hepatocellular CarcinomaActive, not recruitingPhase 32026-06-09NCT06900543